Presented by the Chao Family Comprehensive Cancer Center and Cambridge Healthtech Institute and held at the University of California, Irvine Student Center
A number of breakthrough technologies are being incorporated into novel diagnostics to detect a range of molecular and protein biomarkers. The diagnostic methods applied will include PCR, microarrays, sequencing, proteomics, methylation, and mutation detection. This meeting will highlight the next generation of diagnostic platforms that encompass the latest trends in microfluidics, point-of-care technologies, in vivo sensing, and consumer-driven products. A panel of experts will focus on translation to the medical community and the key to success in implementation.
Scientific Advisory Board:
© 2013 Bioscreening.com